Back to Screener

Healthcare

Viridian Therapeutics, Inc.(VRDN)

Live Price

Offline

$16.63

-0.48% today

1Y Change

+11.15%

Window

Jun 23, 2025 โ†’ Jun 12, 2026

Market Cap
$1.19B
Revenue Growth
+23359.9%
EPS Growth
+16.6%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 23, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Viridian Therapeutics, Inc. (VRDN) is a Healthcare stock with a market cap of $1.19B and listed on NASDAQ. The stock last traded around $16.63 and up 11.1% across the available one-year price window (Jun 23, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of +23359.9%, EPS growth of +16.6%, a dividend yield of 0.0%. What stands out right now is revenue +23359.9%, EPS +16.6%, free cash flow -18.9% with operating margin -512.9% and ROIC -43.8%. Valuation already assumes a fairly strong business story at price/sales 16.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines VRDN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

VRDN

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

VRDN Max Drawdown

-60.63%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for VRDN and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 5, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 5, 26
โ€”
Est -1.05
โ€”
โ€”
Est 33.3B
โ€”
May 5
โ€”
Feb 26, 26
โœ—
-1.08
Est -0.90
-20.0%
132.0B
Est 18375.2B
-99.3%
Feb 26
โ€”
Nov 5, 25
โœ“
-0.34
Est -0.82
+58.5%
70570.0B
Est 15750.1B
+348.1%
Nov 5
โ€”
Aug 6, 25
โ€”
-1.00
Est -1.00
0.0%
75.0B
Est โ€”
โ€”
Aug 6
โ€”
May 6, 25
โœ“
-0.87
Est -0.95
+8.4%
72.0B
Est 44.1B
+63.3%
May 6
โ€”
Feb 27, 25
โœ“
-0.81
Est -1.05
+22.9%
72.0B
Est 50.0B
+44.0%
Feb 27
โ€”
Nov 12, 24
โœ—
-1.15
Est -1.06
-8.5%
86.0B
Est 50.0B
+72.0%
Nov 12
โ€”
Aug 8, 24
โœ—
-1.02
Est -0.89
-14.6%
72.0B
Est 80.0B
-10.0%
Aug 8
โ€”
May 8, 24
โœ“
-0.79
Est -1.10
+28.2%
72.0B
Est 70.0B
+2.9%
May 8
โ€”
Feb 27, 24
โœ—
-1.35
Est -1.00
-35.0%
72.0B
Est 154.2B
-53.3%
Feb 27
โ€”
Nov 13, 23
โœ“
-1.09
Est -1.27
+14.2%
72.0B
Est 160.0B
-55.0%
Nov 13
โ€”
Aug 8, 23
โœ“
-1.27
Est -1.29
+1.6%
72.0B
Est 100.0B
-28.0%
Aug 8
โ€”
May 9, 23
โœ—
-1.61
Est -1.02
-57.8%
98.0B
Est 100.0B
-2.0%
May 9
โ€”
Mar 8, 23
โœ—
-1.13
Est -0.73
-54.8%
105.0B
Est 510.0B
-79.4%
Mar 8
โ€”
Nov 14, 22
โœ“
-0.86
Est -1.02
+15.7%
1195.0B
Est 303.3B
+294.0%
Nov 14
โ€”
Aug 15, 22
โœ—
-1.06
Est -0.90
-17.8%
256.0B
Est 270.3B
-5.3%
Aug 15
โ€”
May 12, 22
โœ“
-0.98
Est -1.08
+9.3%
216.0B
Est 253.5B
-14.8%
May 12
โ€”
Mar 10, 22
โœ—
-1.32
Est -0.85
-55.3%
214.0B
Est 342.8B
-37.6%
Mar 10
โ€”
Nov 4, 21
โœ“
-1.25
Est -1.47
+15.0%
208.0B
Est 570.0B
-63.5%
Nov 4
โ€”
Aug 11, 21
โœ—
-2.21
Est -1.52
-45.4%
1090.0B
Est 762.9B
+42.9%
Aug 11
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener